Share
Dr. Julianne Berry
Kenox Pharmaceuticals Inc. has appointed Dr. Julianne Berry as Vice President of Research & Development and Manufacturing.
In this leadership role, Dr. Berry will oversee Kenox’s integrated development, manufacturing, and testing operations, focusing on enhancing innovation, quality, and operational efficiency across the company’s expanding portfolio of inhaled, nasal, and ophthalmic drug–device combination products.
With over 30 years of experience in the research, development, and commercialization of respiratory and specialty pharmaceutical products, Dr. Berry brings a wealth of expertise to Kenox. She has contributed to the successful launch of multiple marketed therapies, including metered dose inhalers, nasal sprays, dry powder inhalers, and nebulizers, and is widely recognized for her leadership in advancing respiratory drug delivery technologies.
Throughout her distinguished career, Dr. Berry has held senior leadership positions at Schering-Plough, Merck, Novel, Lupin, Glenmark, and Odin, where she played an instrumental role in developing and scaling respiratory and specialty formulations for both U.S. and international markets.
Her appointment represents a significant milestone in Kenox’s continued growth, underscoring the company’s commitment to strengthening its integrated R&D, fill-finish, and analytical capabilities to better serve its pharmaceutical and biotech partners worldwide. With Dr. Berry’s strategic vision and deep technical expertise, Kenox aims to further accelerate its innovation pipeline and global development footprint.
